Change and Clinical Significance of Plasma CD62p, IL-6 in Patients with Cerebral Infarction

HUANG Xiao-song,YANG Qi-dong,LIU Yun-hai,XIAO Bo,LIU Zun-jing,LI Zhen-guo

DOI: https://doi.org/10.3969/j.issn.1672-2019.2005.05.001

2005-01-01

Abstract:Objective To analyze the change and clinical significance of plasma CD62p, IL-6 in the patients with cerebral infarction, and to explore the pathologic mechanism of the brain ischemia. [Methods] The levels of Plasma CD62p, IL-6 were measured by ELISA and radioimmunoassy 60 patients at 48 hours, 6~8 days and 15 days after ischemia. The levels of plasma CD62p, IL-6 of 30 healthy person mating cerebral infarction group in sex and ages were measured. The subsequent volume of brain lesion as a consequence of stroke was measured by CT within 48~72 hours after the onset. [Results] The levels of plasma CD62p, IL-6 in the patients with acute cerebral infarction were obvious higher than the levels of the healthy control groups(P0.001); The levels of plasma CD62p, IL-6 declined gradually with the time of the onset. The level of Plasma CD62p at 48 hours [(9.25±1.82) ng/mL] was obvious higher than the levels 6~8 days [(7.12± 1.75) ng/mL] and 15 days [( 3.55±1.43)ng/mL], the differences were obvious (P0.01); The levels of plasma CD62p, IL-6 in the patients with acute cerebral infarction at 6~8 day were also higher than the levels of the healthy control groups (P0.001); The levels of plasma CD62p,IL-6 at 6~8 days after the onset were positive correlation with the infarct volume (r =0.368, P0.05 and r =0.594, P0.01); There was a positive correlation between the levels of plasma CD62p and the levels of plasma IL-6. [Conclusion] The levels of plasma CD62p, IL-6 were upregulated, which might play a role in inflammatory lesion, and the upregulation of CD62p may be related to the IL-6, The levels of plasma CD62p, IL-6 may reflect both the degree of pathologic lesion after the brain ischemia and the infarct volume.